Peripheral Vascular Devices Market, By Product Type (Peripheral Vascular Stents, Peripheral Transluminal Angioplasty Balloon Catheters, PTA Guidewires, Atherectomy Devices, Chronic Total Occlusion Devices, Aortic Stents, Synthetic Surgical Grafts, Embolic

Peripheral Vascular Devices Market, By Product Type (Peripheral Vascular Stents, Peripheral Transluminal Angioplasty Balloon Catheters, PTA Guidewires, Atherectomy Devices, Chronic Total Occlusion Devices, Aortic Stents, Synthetic Surgical Grafts, Embolic Protection Devices, Inferior Vena Cava Filters), By End User (Hospitals, Clinics, Ambulatory Surgical Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Peripheral vascular disease (PVD), also known as arteriosclerosis obliterans, arterial insufficiency of the legs, claudication, or intermittent claudication, is a blood circulation disorder that causes the blood vessels in the heart or brain to narrow, spasm or block. Peripheral vascular disease usually causes fatigue and pain in the legs and particularly during strenuous physical activities, which usually subsides with rest. The blood vessels supplying oxygenated blood to the arms, kidneys, intestines, and stomach are usually affected by the peripheral vascular devices. According to the Center for Disease Control and Prevention, around 12 to 20 percent of the population in the age category of 60 years and above, developed PAD, in 2016. The incidence rate of this disease is steadily increasing.
Restraints of the Global Peripheral Vascular Devices Market
Major factors hampering the growth of the peripheral vascular devices market during the forecast period constitutes of product recalls, and infection related issues.
Key features of the study:
This report provides in-depth analysis of the global peripheral vascular devices market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global peripheral vascular devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Abbot Laboratories, Boston Scientific Corporation, Angioscore, Emboline Inc., Becton Dickinson, and Company, Cook Group Inc., Cordis Corporation, Covidien PLC, Edward Lifesciences Corporation, Medtronic Plc, St. Jude Medical, and Bayer AG.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global peripheral vascular devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Peripheral Vascular Devices Market, By Product Type:
Peripheral Vascular Stents
Peripheral Transluminal Angioplasty Balloon Catheters
PTA Guidewires
Atherectomy Devices
Chronic Total Occlusion Devices
Aortic Stents
Synthetic Surgical Grafts
Embolic Protection Devices
Inferior Vena Cava Filters
Global Peripheral Vascular Devices Market, By End User:
Hospitals
Clinics
Ambulatory Surgical Centers
Global Peripheral Vascular Devices Market, By Geography:
North America
By Product Type
Peripheral Vascular Stents
Peripheral Transluminal Angioplasty Balloon Catheters
PTA Guidewires
Atherectomy Devices
Chronic Total Occlusion Devices
Aortic Stents
Synthetic Surgical Grafts
Embolic Protection Devices
Inferior Vena Cava Filters
By End User
Hospitals
Clinics
Ambulatory Surgical Centers
By Country:
U.S.
Canada
Europe
By Product Type
Peripheral Vascular Stents
Peripheral Transluminal Angioplasty Balloon Catheters
PTA Guidewires
Atherectomy Devices
Chronic Total Occlusion Devices
Aortic Stents
Synthetic Surgical Grafts
Embolic Protection Devices
Inferior Vena Cava Filters
By End User
Hospitals
Clinics
Ambulatory Surgical Centers
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type
Peripheral Vascular Stents
Peripheral Transluminal Angioplasty Balloon Catheters
PTA Guidewires
Atherectomy Devices
Chronic Total Occlusion Devices
Aortic Stents
Synthetic Surgical Grafts
Embolic Protection Devices
Inferior Vena Cava Filters
By End User
Hospitals
Clinics
Ambulatory Surgical Centers
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Product Type
Peripheral Vascular Stents
Peripheral Transluminal Angioplasty Balloon Catheters
PTA Guidewires
Atherectomy Devices
Chronic Total Occlusion Devices
Aortic Stents
Synthetic Surgical Grafts
Embolic Protection Devices
Inferior Vena Cava Filters
By End User
Hospitals
Clinics
Ambulatory Surgical Centers
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Product Type
Peripheral Vascular Stents
Peripheral Transluminal Angioplasty Balloon Catheters
PTA Guidewires
Atherectomy Devices
Chronic Total Occlusion Devices
Aortic Stents
Synthetic Surgical Grafts
Embolic Protection Devices
Inferior Vena Cava Filters
By End User
Hospitals
Clinics
Ambulatory Surgical Centers
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type
Peripheral Vascular Stents
Peripheral Transluminal Angioplasty Balloon Catheters
PTA Guidewires
Atherectomy Devices
Chronic Total Occlusion Devices
Aortic Stents
Synthetic Surgical Grafts
Embolic Protection Devices
Inferior Vena Cava Filters
By End User
Hospitals
Clinics
Ambulatory Surgical Centers
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Abbot Laboratories*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Boston Scientific Corporation
Angioscore
Emboline Inc.
Becton Dickinson, and Company
Cook Group Inc.
Cordis Corporation
Covidien PLC
Edward Lifesciences Corporation
Medtronic Plc
St. Jude Medical
Bayer AG
“*” marked represents similar segmentation in other categories in the respective section.